Ascendis Pharma (ASND) Given Consensus Rating of “Buy” by Analysts

Retrieved on: 2018-05-21 05:33:22

Tags for this article:

Click the tags to see associated articles and topics

Ascendis Pharma (ASND) Given Consensus Rating of “Buy” by Analysts. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc bought a new stake in Ascendis Pharma during the 1st quarter valued at $162,160,000. Farallon Capital Management LLC ...</div>

Article found on:

View Original Article